Oncolys believes partnerships and collaboration is the key to bring rare and intractable disease treatments a breakthrough.

Oncolys' mission is to develop safe, effective and innovative drugs and therapeutics based on virology, to bring hope and to improve the life of patients suffering from rare and intractable diseases. We place high value on partnering with companies and organizations who have competitive edge that complements us and strengthens our capacity to realize this mission. We look forward to new opportunities to collaborate with potential partners on innovative drug candidates in order to create and deliver value to patients as soon as possible. Areas we are particularly interested in are the followings:

Key Areas of Interest
  • Cancer (other than blood cancer)
  • Cancer immunology
  • Gene therapy
  • Rare diseases / diseases caused by gene mutation (inherited diseases)
  • Viral infections
  • Small molecule drugs

For more information about partnering opportunities, please contact us here.
For inquiries from outside Japan, you can also contact our US business development base Oncolys USA.

Contact us

Further information on Oncolys BioPharma's Research & Development Network »